Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
SynDevRx (United States)
h-index: 2
Total citations: 34
Total papers: 6
Homepage:
https://syndevrx.com/
Recent papers from SynDevRx (United States)
Obesity Accelerates Multiple Myeloma Progression in Certain Mouse Models and in Humans
Cancer Prevention Research · 2026
Evexomostat (SDX-7320), a methionine aminopeptidase type 2 inhibitor, stimulates weight loss and inhibits obesity-accelerated tumor growth
Frontiers in Oncology · 2026
A Phase 1 Safety Study of Evexomostat (SDX-7320) in Patients with Late-Stage Cancer: An Antiangiogenic, Insulin-Sensitizing Drug Conjugate Targeting METAP2
Cancer Research Communications · 2025
Pharmacological Characterization of SDX-7320/Evexomostat: A Novel Methionine Aminopeptidase Type 2 Inhibitor with Anti-tumor and Anti-metastatic Activity
Molecular Cancer Therapeutics · 2024
Pharmacological Characterization of SDX-7320/Evexomostat: a Novel Methionine Aminopeptidase Type 2 Inhibitor with Anti-Tumor and Anti-Metastatic Activity
2024
Dehydro-α-lapachone, a plant product with antivascular activity
Proceedings of the National Academy of Sciences · 2011